Tag: pharma services
Anthem Biosciences IPO Eyes 31% Pop as Grey Market Premium Soars: Is the Hype Justified?
Anthem Biosciences is making waves with its ₹3,395 crore IPO, drawing high subscription rates and a surging grey market premium pointing to a strong debut. But with the offer for sale structure and GMP unpredictability, investors need to weigh the promise against the risks.
Read more